Combination antibiotic susceptibility testing to treat exacerbations of cystic fibrosis associated with multiresistant bacteria: a randomised, double-blind, controlled clinical trial

Shawn D. Aaron(Ottawa Hospital), Noni E. MacDonald(Dalhousie University), Yves Berthiaume(Montreal Clinical Research Institute), Mary Noseworthy(Memorial University of Newfoundland), Wendy Ferris(University of Ottawa), Anne L. Stephenson(St. Michael's Hospital), Pearce Wilcox(University of British Columbia), Steve Doucette, Dean Fergusson, V. Yozghatlian(Royal Prince Alfred Hospital), Colin Harbour(The University of Sydney), Peter T.P. Bye(Royal Prince Alfred Hospital), Elizabeth Tullis(University of Toronto), Francis Chan(University of Ottawa), Katherine L. Vandemheen, Nigel A. M. Paterson(Western University), Michel Ruel(Université Laval), Alphonse Jeanneret(Université de Montréal), Barbara Rose(The University of Sydney), David Haase(Dalhousie University), Scott C. Bell(Douglas Mental Health University Institute), Neil E. Brown(University of Alberta), Andreas Freitag(McMaster University)
The Lancet
August 1, 2005
Cited by 238


Related Papers